Vincent Ippolito
MD & Government Chairman
Good night, everybody. Apologies for simply the slight delay in logging in right here. We have now near 400 individuals preregistered for the occasion, however we’re on the backside of the hour right here, so we’ll get began. So everybody becoming a member of us from North America, good night; everybody from Australia, a nice good morning to all of you. I am Vincent Ippolito, Government Chairman of the Board of Botanix Prescribed drugs, and we’re happy to current the Botanix quarterly exercise report and 4C quarterly money move report for the interval ending 31 December 2025.
As we speak, we’re talking to you reside from the 2026 Botanix Nationwide Gross sales Assembly. It is an annual gathering of our gross sales professionals and firm staff. Right here, we do superior coaching with the gross sales representatives, lay out the important thing aims and techniques for the upcoming quarters. However most significantly, we acknowledge excellent gross sales efficiency from our high gross sales representatives. And as you’ll think about, there’s loads of excessive power and enthusiasm from our worker base on our first profitable launch 12 months right here at Botanix. And it was simply 1 12 months in the past, we have been on the firm’s first nationwide gross sales assembly making ready our gross sales professionals to launch Sofdra the week after they left. The corporate has come a good distance up to now 11 months, that is in 2025, since that extremely profitable industrial launch of Sofdra. And we’re more than happy with the progress that we have made and consider that we’re nicely positioned for future development.
